Showing results (11-20 of 137) with videos related to
Sort By:
Pageof 14
Cancer Chemotherapy Reports|March 1, 1975
Clinical trials with 1-acetyl-2-picolinoylhydrazine (NSC-68626) in childrenW W Sutow, D Komp, T J Vietti, et al.Medical and Pediatric Oncology|January 1, 1979
Evaluation of overall toxicity of high-dosage methotrexate regimensC Perez, W W Sutow, Y M Wang, et al.Cancer Clinical Trials|January 1, 1978
Prognosis after metastases in osteosarcomaC Perez, J Herson, J C Kimball, et al.Cancer Clinical Trials|January 1, 1978
Significance of the 48-hour plasma level in high-dose methotrexate regimensC Perez, Y M Wang, W W Sutow, et al.Clinical Chemistry|May 1, 1980
Plasma methotrexate as determined by liquid chromatography, enzyme-inhibition assay, and radioimmunoassay after high-dose infusionS K Howell, Y M Wang, R Hosoya, et al.Journal of the National Cancer Institute|June 1, 1979
Risk of radiation-related subsequent malignant tumors in survivors of Ewing's sarcomaL C Strong, J Herson, B M Osborne, et al.Cancer Treatment Reports|March 1, 1979
Age-related pharmacokinetics of high-dose methotrexate in patients with osteosarcomaY M Wang, W W Sutow, M M Romsdahl, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 1, 1982
[Experimental study on pharmacokinetics of methotrexate and its metabolite (7-hydroxy-methotrexate) in tissue]K Sasaki, R Hosoya, Y M Wang, et al.Urology|January 1, 1982
Preoperative chemotherapy for Wilms tumorR B Bracken, W W Sutow, N Jaffe, et al.American Journal of Clinical Pathology|May 1, 1977
Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54G Uribe-Botero, W O Russell, W W Sutow, et al.Pageof 14